Trials / Recruiting
RecruitingNCT06420427
Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery
Dynamic Monitoring of Circulating Tumor DNA (ctDNA) and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery/Treatment
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assess the sensitivity, specificity, positive predictive value, and negative predictive value of dynamic monitoring of circulating tumor DNA (ctDNA) combined with circulating HPV DNA (cfHPV DNA) for early prediction of recurrence in cervical cancer post-surgery or post-treatment, and compare its advantages and disadvantages with existing diagnostic methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Assess the risk of recurrence and the efficacy of medication | Evaluation of recurrence risk and medication efficacy through liquid biopsy |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-12-31
- Completion
- 2027-01-30
- First posted
- 2024-05-20
- Last updated
- 2024-05-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06420427. Inclusion in this directory is not an endorsement.